VAGILIA Drug Patent Profile
✉ Email this page to a colleague
When do Vagilia patents expire, and when can generic versions of Vagilia launch?
Vagilia is a drug marketed by Cosette and is included in one NDA.
The generic ingredient in VAGILIA is triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole). There are five drug master file entries for this compound. Additional details are available on the triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VAGILIA?
- What are the global sales for VAGILIA?
- What is Average Wholesale Price for VAGILIA?
Summary for VAGILIA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 125 |
| Patent Applications: | 4,106 |
| DailyMed Link: | VAGILIA at DailyMed |
US Patents and Regulatory Information for VAGILIA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cosette | VAGILIA | triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) | CREAM;VAGINAL | 088821-001 | Nov 9, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
